Drug profile

The FDA adverse-event record for Meloxicam Injection

37 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Meloxicam Injection. Species, reactions, and outcomes follow.

#1304 of 2,679
by report volume (all drugs)
37
adverse-event reports
21.6%
death-coded share
Cat
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Meloxicam Injection ranks #1300 of 2679 by total reports (37). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1300
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Meloxicam Injection has 37 reports now versus 35 in that prior snapshot: 2 more (5.7%).

Report change
+2
Death-coded reports
+0
Death-coded share
−1.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Meloxicam Injection changes

Signature read: Meloxicam Injection's 21.6% death-coded share is among the highest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
37
Total Reports
8
Deaths Reported
21.6%
Death-coded share of reports

Active Ingredients

Meloxicam Injection

Administration Routes

ParenteralUnknownSubcutaneousIntravenousOther

Species Affected

Cat 19
Dog 18

Most Affected Breeds

Domestic Shorthair 13
Beagle 3
Chihuahua 2
Domestic Mediumhair 2
Bichon Frise 1
Dachshund - Standard Long-haired 1
Terrier - Rat 1
Bulldog - American 1
Schnauzer - Miniature 1
Greyhound 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 10
Not eating 8
Behavioural disorder NOS 7
Not sleeping 7
Other abnormal test result NOS 7
Anorexia 6
Dehydration 6
Vocalisation 5
Vomiting 5
Hypoproteinaemia 5
Restlessness 5
Peritonitis 4

Outcome Breakdown

Ongoing
12 (32.4%)
Recovered/Normal
11 (29.7%)
Outcome Unknown
6 (16.2%)
Euthanized
4 (10.8%)
Died
4 (10.8%)

Meloxicam Injection: high death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Meloxicam Injection (#1304 of 2,679 by report volume); death-coded 21.6%. PlainBreed drug row · death-coded share stamp 21.6% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →